The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
APOLLO ENDOSURGERY INC COM 03767D108 25,676 3,169,845 SH   SOLE   3,169,845 0 0
INSTIL BIO INC COM 45783C101 163,810 8,478,790 SH   SOLE   8,478,790 0 0
INVESCO QQQ TR UNIT SER 1 46090E103 5,394 15,219 SH   SOLE   15,219 0 0
REATA PHARMACEUTICALS INC CL A 75615P103 409,998 2,896,901 SH   SOLE   2,896,901 0 0